Wai Yuen Tong Medicine Holdings Limited (HKG:0897)

HKG:0897 Revenue

In the fiscal year ending March 31, 2026, Wai Yuen Tong Medicine Holdings had annual revenue of 683.44M HKD, down -8.30%. Wai Yuen Tong Medicine Holdings had revenue of 360.63M in the half year ending March 31, 2026. That makes Wai Yuen Tong Medicine Holdings the 23,729th largest company in the world by revenue and 1,409th in Hong Kong.

• Revenue: 683.44M
• Revenue Growth: -8.30%
• P/S Ratio: 0.59
• Revenue / Employee: 989.06K
• Employees: 691
• Market Cap: 401.18M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chinese Pharmaceutical 607.17M 88.3%
• Western Pharmaceutical 74.03M 10.8%
• Property Investment 6.47M 0.9%

By Geography

Chart

• Hong Kong 523.99M 76.7%
• Mainland China 96.10M 14.1%
• Macau 59.06M 8.6%
• Others 4.30M 0.6%

Fiscal year ended Mar 31, 2026 See the full HKG:0897 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	683.44M	-61.86M	-8.30%
Mar 31, 2025	745.30M	-38.58M	-4.92%
Mar 31, 2024	783.88M	60.28M	8.33%
Mar 31, 2023	723.60M	-667.81M	-48.00%
Mar 31, 2022	1.39B	282.85M	25.51%

Data Source: S&P Global Market Intelligence Last updated: Jul 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 30, 2026

Data Sources Report a data error